Rockefeller Capital Management’s Apyx Medical APYX Stock Holding History

Rockefeller Capital Management’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,700	Closed	-$11K	–	4089
2022 Q1	$11K	Hold	1,700	–	–	﹤0.01%	2979
2021 Q4	$21K	Hold	1,700	–	–	﹤0.01%	2619
2021 Q3	$23K	Hold	1,700	–	–	﹤0.01%	2515
2021 Q2	$17K	Hold	1,700	–	–	﹤0.01%	2544
2021 Q1	$16K	Buy	+1,700	New	+$17K	﹤0.01%	2368

Other funds holding APYX

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PVI

Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return

KLC

Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

HKAM

Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.89B AUM 151.53% 1-Year Est. Return

Invenire Partners Ridgefield, Connecticut $65.4M AUM 18.1% 1-Year Est. Return

Rockefeller Capital Management's APYX Position: Q2 2022 in Review

Rockefeller Capital Management sold out of Apyx Medical (APYX) in Q2 2022, closing a stake of 1,700 shares — an estimated $11K sold.

Rockefeller Capital Management first reported a position in APYX in Q1 2021 and held it in 5 quarters. The position peaked at $23K in Q3 2021. 63 funds tracked by Wall St. Rank hold APYX as of Q2 2022.

Rockefeller Capital Management reported no remaining Apyx Medical position as of Q2 2022 after selling out during the quarter.
Rockefeller Capital Management sold 1,700 Apyx Medical shares in Q2 2022, an estimated $11K.
Rockefeller Capital Management first reported a position in Apyx Medical in Q1 2021 and held it in 5 quarters.
Rockefeller Capital Management's Apyx Medical position peaked at $23K in Q3 2021.
63 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2022.

Based on Rockefeller Capital Management's 13F filing for Q2 2022, filed 12 Aug 2022.